Nevada’s Vetoed Insulin Cost Transparency Bill Returns, as California Advances Several Pricing Measures By Sam | June 5, 2017 Lawmakers in Nevada and California continue to target drugmakers in health care proposals. Source: Drug Industry Daily Posted in Drug Industry Daily